UCB's Keppra Gains Indication As Adjunctive Therapy For Juvenile Myoclonic Epilepsy
This article was originally published in The Pink Sheet Daily
Executive Summary
New indication represents the first U.S. approval for Keppra for the treatment of a generalized seizure type in epilepsy patients.